World-first research will save koalas
The "holy grail" for understanding how and why koalas respond to infectious diseases has been uncovered in an Australian-led, world-first genome mapping project.
Apr 09, 2013
4.5 / 5 (4)
0
Apr 09, 2013
4.5 / 5 (4)
0
Exposing the secrets of costly viruses
Researchers are making headway in discovering how two harmful viruses – ISAV and IPNV – sidestep the salmon immune system. Effective viral vaccines are now in sight.
Feb 21, 2013
5 / 5 (1)
0
Researchers discover how mole rat wards off cancer
Biologists at the University of Rochester have determined how blind mole rats fight off cancer—and the mechanism differs from what they discovered three years ago in another long-lived and cancer-resistant ...
Nov 05, 2012
4.9 / 5 (8)
4
|
Enhancing the efficacy of immunity-activating nucleic acid drugs
(Phys.org)—The Nanotechnology Innovation Station of the National Institute for Materials Science has succeeded in development of a technology which utilizes nanoparticles to enhance the action of immunity ...
Aug 23, 2012
5 / 5 (1)
0
|
New findings on the diagnosis of paratuberculosis in goats
Measuring immune responses with the help of a so-called interferon gamma test can help to diagnose paratuberculosis in goats.
Jun 11, 2012
not rated yet
0
US panel gives nod to Merck hepatitis C drug
A US government advisory committee on Wednesday unanimously voted to urge the Food and Drug Administration to approve a new drug made by Merck to fight hepatitis C, a disease which attacks the liver.
Apr 27, 2011
5 / 5 (1)
0
Novel method could improve the performance of proteins used therapeutically
Whitehead Institute scientists have created a method that site-specifically modifies proteins to exert control over their properties when administered therapeutically. The technique should be useful to increase potency, slow ...
Mar 09, 2011
not rated yet
0
|
Macavity wasn't there! How absent reoviruses kill cancer
Reoviruses are successfully being used in clinical trials to treat patients with cancer. Not only does the virus cause cancer cells to die, it also forces them to release pro-inflammatory chemokines and cytokines, which in ...
Feb 21, 2011
5 / 5 (1)
1
Study finds twenty percent of children with MS don't respond to first-line treatment
Researchers from the National Network of Pediatric MS Centers of Excellence, in the first retrospective study of the response of children with multiple sclerosis to standard, or first-line, therapies, found that one-fifth ...
Jan 26, 2011
3 / 5 (1)
0
Interfering with a double-edged sword: Novel anti-inflammatory functions for interferons
One of the body's first protective reactions to infection is inflammation, typically stimulated by the factor IL-1beta. Unfortunately, inflammation frequently occurs when it is not desired and so must be treated, e.g. by ...
Sep 15, 2010
not rated yet
0
New anti-viral drug shows promise for dramatic improvement in hepatitis C treatment
Adding a direct acting anti-viral drug to the standard treatment regimen for hepatitis C significantly increases the cure rate in the most difficult to treat patients, according to a research report published Monday in the ...
Aug 08, 2010
5 / 5 (3)
0
Gene variant may increase severity of MS
A new study shows a gene variant may increase the severity of multiple sclerosis (MS) symptoms. The research will be published in the August 3, 2010, issue of Neurology, the medical journal of the American Academy of Neu ...
Aug 02, 2010
not rated yet
0
Interferon might help asthma patients breathe easier, study suggests
An immune-system protein already used to treat diseases like multiple sclerosis, hepatitis C and a variety of cancers might also aid asthma patients, UT Southwestern Medical Center researchers have found.
Jul 13, 2010
not rated yet
0
Gamma interferon a wake-up call for stem cell response to infection
Most of the time, the body's blood-forming (hematopoietic) stem cells remain dormant, with just a few producing blood cells and maintaining a balance among the different types.
Jun 09, 2010
5 / 5 (1)
0
|
A clamp for emerging flu viruses
When the human body becomes infected with new influenza viruses, the immune system rapidly activates an inborn protective mechanism to inhibit the intruding pathogen. A protein known as Mx plays an important role in this ...
Apr 28, 2010
not rated yet
0
